FDA advisory committee

FDA Adcomm
Pharma

FDA advisors vote against GSK's Blenrep comeback

Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with side effects, proposed dosing and a lack of diversity in GSK's trials.
Zoey Becker Jul 17, 2025 3:14pm
FDA

FDA questions Rexulti efficacy in PTSD after failed phase 3

Jul 16, 2025 2:38pm
Pfizer

FDA advisors unanimously reject Pfizer's Talzenna expansion bid

May 22, 2025 10:20am
Darzalex Faspro

FDA advisors back Darzalex as treatment for early myeloma

May 21, 2025 8:52am
FDA stop sign

FDA leaders push for more US enrollment in cancer trials

May 20, 2025 12:52pm
FDA

J&J, Pfizer and Roche face FDA questions over data applicability

May 16, 2025 3:52pm